- Home
- ACTU vs IDR Comparison
ACTU vs IDR Comparison
Compare ACTU & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- IDR
- Stock Information
- Founded
- ACTU 2015
- IDR 1996
- Country
- ACTU United States
- IDR United States
- Employees
- ACTU N/A
- IDR N/A
- Industry
- ACTU
- IDR Precious Metals
- Sector
- ACTU
- IDR Basic Materials
- Exchange
- ACTU NYSE
- IDR Nasdaq
- Market Cap
- ACTU 135.0M
- IDR 154.1M
- IPO Year
- ACTU 2024
- IDR N/A
- Fundamental
- Price
- ACTU $7.47
- IDR $13.76
- Analyst Decision
- ACTU Strong Buy
- IDR Strong Buy
- Analyst Count
- ACTU 1
- IDR 1
- Target Price
- ACTU $20.00
- IDR $17.50
- AVG Volume (30 Days)
- ACTU 85.1K
- IDR 315.9K
- Earning Date
- ACTU 05-15-2025
- IDR 07-29-2025
- Dividend Yield
- ACTU N/A
- IDR N/A
- EPS Growth
- ACTU N/A
- IDR 144.40
- EPS
- ACTU N/A
- IDR 0.62
- Revenue
- ACTU N/A
- IDR $27,144,971.00
- Revenue This Year
- ACTU N/A
- IDR $9.76
- Revenue Next Year
- ACTU N/A
- IDR N/A
- P/E Ratio
- ACTU N/A
- IDR $22.27
- Revenue Growth
- ACTU N/A
- IDR 67.42
- 52 Week Low
- ACTU $5.51
- IDR $8.90
- 52 Week High
- ACTU $11.99
- IDR $19.75
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- IDR 48.18
- Support Level
- ACTU N/A
- IDR $14.00
- Resistance Level
- ACTU N/A
- IDR $14.79
- Average True Range (ATR)
- ACTU 0.00
- IDR 0.62
- MACD
- ACTU 0.00
- IDR 0.13
- Stochastic Oscillator
- ACTU 0.00
- IDR 43.72
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.